Abril-Junio 2006 N°27
ISSN 1317-987X
 
Buscar




Artículos
 
Introducción
Materiales y Métodos
Resultados
Discusión
Referencias Bibliográficas



Microbiología
Variabilidad en los exoproductos de Pseudomonas aeruginosa aislada de diferentes muestras clínicas

Referencias Bibliográficas

  1. Eykyn S, Gransden W, Phillips I. The causative organisms of septicaemia and their epidemiology. J. Antimicrob Chemother 1990; 25: 41-58.
  2. Trilla A, Barrio J. Infecciones nosocomiales. En: Farreras A, Rozman M, editores. Medicina Interna. Ediciones Mosby-Doyma Libros S.A. 13ra ed. España, 1996: 2553-2558.
  3. Sligl W, Taylor G, Brindley P. Five years of nosocomial Gram-negative bacteremia in a general intensive care unit: epidemiology, antimicrobial susceptibility patterns, and outcomes. Int J Infect Dis 2006; 3: 32-41.
  4. Svensen H, Clifton B, Brauer K, Olsson J, Uchida T, Traber L, ?et al?. Sepsis produced by Pseudomonas bacteremia does not alter plasma volume expansion after 0.9% saline infusion in sheep. Anesth Analg 2005; 101(3):835-842.
  5. Bicanic A, Eykyn J. Hospital-acquired, native valve endocarditis caused by Pseudomonas aeruginosa. J Infect 2002; 44(2):137-139.
  6. Chacko T, Chandy T, Abraham C, Swaminathan S, Varghese M, Priscilla R, Mathai D. Pacemaker endocarditis caused by Pseudomonas aeruginosa treated successfully. J Assoc Physicians India 2003; 51:1021-1022.
  7. Venkatesan A, Spalding C, Speedie A, Sinha G, Rumbaugh J. Pseudomonas aeruginosa infective endocarditis presenting as bacterial meningitis. J Infect 2005; 51(4):199-202.
  8. Goto H, Takeda H, Kawai S, Nakadate T, Shimada K, Nakano K, Suwabe A, Yokouchi H, ?et al?. Susceptibilities of bacteria isolated from patients with lower respiratory infectious diseases to antibiotics. Jpn J Antibiot 2005; 58(3):326-358.
  9. Garcia-Medina R, Dunne M, Singh K, Brody L. Pseudomonas aeruginosa acquires biofilm-like properties within airway epithelial cells. Infect Immun 2005; 73(12):8298-8305.
  10. Chang W, Lu C, Chuang Y. Mixed infection in adult bacterial meningitis. Infections 2000; 25: 8-12.
  11. Schina M, Spyridi E, Daoudakis M, Mertzanos E, Korfias S. Successful treatment of multidrug-resistant Pseudomonas aeruginosa meningitis with intravenous and intrathecal colistin. Int J Infect Dis 2005; 28: 1-10.
  12. Wang W, Chang N, Huang R, Tsai W, Tsui W, Wang C, Su M, Rau S, ?et al?. Post-neurosurgical nosocomial bacterial meningitis in adults: microbiology, clinical features, and outcomes. J Clin Neurosci 2005; 12(6):647-650.
  13. Shah S, Gallagher P. Complications of conjutivitis caused Pseudomonmas aeruginosa in a new born intensive care unit. Pediatr Infect Dis J 1998; 17:97-102.
  14. Huang X, Barrett P, McClellan A, Hazlett D. Silencing Toll-like receptor-9 in Pseudomonas aeruginosa keratitis. Invest Ophthalmol Vis Sci 2005; 46(11):4209-4216.
  15. Cole N, Hume E, Khan S, Krockenberger M, Thakur A, Husband A, Willcox D. Interleukin-4 is not critical to pathogenesis in a mouse model of Pseudomonas aeruginosa corneal infection. Curr Eye Res 2005; 30(7):535-542.
  16. Prutit A, Manus A, Kim S, Goodwing C. Burn Wound Infections: Current Status. World J Surg 1998; 22:135-145.
  17. Vitkauskiene A, Scheuss S, Sahly H, Sakalauskas R, Dudzevicius V. Pseudomonas aeruginosa strains from nosocomial pneumonia are more serum resistant than P. aeruginosa strains from noninfectious respiratory colonization processes. Infection 2005; 33(5-6):356-361.
  18. Andriesse I, Verhoef J. Nosocomial pneumonia: rationalizing the approach to empirical therapy. Treat Respir Med 2006; 5(1):11-30.
  19. Driss N, Mighri K, Hassine M, Ayadi K, Trabelsi M, Braham H. Malignant otitis externa. Tunis-Med 1994; 71(11): 541-545.
  20. Chen S, Chen K, Lin A, Chang Y, Wu H, Hsu T, Chiu A, Chang L. Complicated unitary tract infection: analysis of 179 patiens Chung. Hua I. Hsueh Tsa Chih 1998; 61:651-656
  21. Jones A. Eradication therapy for early Pseudomonas aeruginosa infection in CF: many questions still unanswered. Eur Respir J 2005; 26(3):373-375.
  22. Grandis J, Branstetter B, Yu V. The changing face of malignant (necrotising) external otitis: clinical, radiological, and anatomic correlations. Lancet Infect Dis 2004; 4(1):34-39
  23. Shaver M, Hauser R. Relative contributions of Pseudomonas aeruginosa ExoU, ExoS, and ExoT to virulence in the lung. Infect Immun 2004; 72(12):6969-6977.
  24. Guadarrama S, Pulcini E, Broadaway C, Pyle H. Pseudomonas aeruginosa growth and production of Exotoxin A in static and modeled microgravity environments. Gravit Space Biol Bull 2005; 18(2):85-86
  25. Takumida M, Anniko M. Protective effect of edaravone against the ototoxicity of Pseudomonas aeruginosa exotoxin A. Acta Otolaryngol 2006; 126(1):15-19.
  26. Zhang Y, Barbieri T. A leucine-rich motif targets Pseudomonas aeruginosa ExoS within mammalian cells. Infect Immun 2005; 73(12):7938-7945.
  27. Ciragil P, Soyletir G. Alginate, elastase and alkaline protease production of Pseudomonas aeruginosa strains isolated from various body sites. Mikrobiyol Bul 2004; 38(4):341-347.
  28. Khan S, Misra A, Tripathi C, Mishra B, Bihari V. Response surface optimization of effective medium constituents for the production of alkaline protease from a newly isolated strain of Pseudomonas aeruginosa. Indian J Exp Biol 2006; 44(2):151-156.
  29. Karadzic I, Masui A, Fujiwara N. Purification and characterization of a protease from Pseudomonas aeruginosa grown in cutting oil. J Biosci Bioeng 2004; 98(3):145-152.
  30. Jaffar C. Production of elastase, exotoxin A and alkaline protease in sputa during pulmonary exacerbation of cystic fibrosis in patients chronically infected by Pseudomonas aeruginosa. Journal Clinical Microbiology 1995; 33(4):924-929.
  31. Kohler W. Zentralblatt fur, Bakteriologie-100 years ago: evidence for a haemolysin produced by Pseudomonas aeruginosa. Int J Med Microbiol 2000; 290(3):205-206.
  32. Barker A, Vasil A, Filloux A, Ball G, Wilderman P, Vasil M. A novel extracellular phospholipase C of Pseudomonas aeruginosa is required for phospholipid chemotaxis. Mol Microbiol 2004; 53(4):1089-1098.
  33. Sato H, Okinaga K, Saito H. Rol of pili in the pathogenesis of Pseudomonas aeruginosa burn infection. Microbiol. Immunol 1998; 32(2): 131-139
  34. Anastassiou E., Mintzas A., Kounavis C., Dimitracopoulus G. 1987. Alginate production by clinical non mucoid Pseudomonas aeruginosa strains. Journal of clinical Microbiology. 25(4): 656-659.
  35. Murray P., Baron E., Jorgensen J., Pfatler M., Yolken R.: Manual of Clinical Microbiology. 8th edition. American Society for Microbiology. ASM Press Washinton, D.C. 2.003.
  36. Briceño, E; Suárez, E.; Michelangi, C.; Feliciangeli, D.; Ptaiza, E.; Mendible, J.; Villalón, M.; Aguilera, M.; Ceballo, H.; Godoy, J. y Col. 2002. Código de Bioética y Bioseguridad, Capítulo 2 y 3. Ministerio de Ciencia y Tecnología (FONACIT). 2da Edición. Venezuela.
  37. Thomson, R; Miller, M. 2003. Specimen Collection, Transport, and Processing: Bacteriology. En Murray, P. Baron E., Jorgensen, J., Pfaller, M., Yolken R. Manual of Clinical Microbiology. 8th edition. American Society for Microbiology. ASM Press Washinton, D.C. 2.003. pp. 286-330.
  38. Kiska, D.; Gilligan, P. 2003. Pseudomonas. En Murray, P. Baron E., Jorgensen, J., Pfaller, M., Yolken R. Manual of Clinical Microbiology. 8th edition. American Society for Microbiology. ASM Press Washinton, D.C. 2.003. pp. 719-728.
  39. NCCLS. Performance Standards for Anmicrobial Disk Susceptibility Test. Approved standard M2-A7. NCCLS, Wayne, Pa, 2000.
  40. Lowry O, Rosebrough N, Farr A, Randall R. Protein measurement with folin phenol reagents. J. Biol. Chem 1951; 193: 265-270.
  41. Herbert D, Phipps P, Straone R. Automated chemical analysis. En: Norris J, Ribbons D, editores. Methods in Microbiology. Academic Press 5, 1983: 209-344.
  42. Laemmli U. Clivage of structural proteins during the assembly for the head of bacteriophage T4. Nature 1970; 227: 680-685.
  43. Hamood A, Griswold J, Duhan C. Production of extracellular virulence factors by Pseudomonas aeruginosa iolates obtained from tracheal, urinary tract, and wound infections. Journal of surgical Research 1996; 61: 425-432.
  44. Rumbaugh P, Hamood A, Griswold J. Analysis of Pseudomonas aeruginosa clinical isolates for possible variations within the virulence genes exotoxin A and Exoenzyme S. Journal of Surgical Reseach 1999; 82:95-105.
  45. Rumbaugh K, Abdul B, Hamood A, Griswold J. Analysis of Pseudomonas aeruginosa Clinical Isolates for Possible Variations within the Virulence Genes Exotoxin A and Exoenzyme S. Journal of Surgical Research 1999; 82(1): 95-105.
  46. Sokol P, Iglewski B, Hager T, Sadof C, Cross A, McManus A, Faber F, Iglewski W. Production of exoenzyme S by clinical isolates of Pseudomonas aeruginosa. Infect Immun 1981; 34:147-153.
  47. Woods D, Sokol P. Use of tramposon mutants to assess the role of exoenzyme S in chronic pulmonary disease due to Pseudomonas aeruginosa. Eur J Clin Microbiol 1985; 4:163-169.
  48. Shattielz Z, Bernadini L, Wisnieski J. Caracterization of the insertion of Pseudomonas exotoxina A into membranes. Infection and Immun 1985; 50(3):630-635.
  49. Quetin R, Bollet C, Dayan A, Martin C, Goudeau A, De micco P. Pseudomonas aeruginosa and cystic fibrosis: intrastrain variability in relation to intensity of immune response and chemical outcome. Microbiological 1993; 16(2): 185-188.
  50. Costa M, Gómez F, Molina L, Simpson R, Romero A. Purificación y caracterización de proteasas de Pseudomonas fluorescens y sus efectos sobre lãs proteínas de la leche. Archivos Latinoamericano de Nutrición 2002; 52(2): 160-166.
  51. Marquart M, Caballero A, Chomnaw M, Thibodeaux B, Twining S, O´Callaghan R. Identification of a novel secreted protease from Pseudomonas aeruginosa that causes corneal erosions. Invest Ophthalmol Vis Sci 2005; 46(10): 3761-3768.
  52. Rubiere-Huet J, Di Martino P, Gallet O, Hulen C. Interations of the Pseudomonas aeruginosa outer membrane proteins with plasma fibronectins. Bacterial adhesin investigation. C R Acad Sci 1999; 322: 1971-1980.
  53. Feldman M, Bryan R, Rajan S, Scheffler L, Brunnert S, Tang H, Prince A. Rol of flagella in pathogenesis of Pseudomonas aeruginosa pulmonary infection. Infect Inmun 1998; 66: 43-51.
  54. Holt P, Misfeldt M. Alteration of murine immune response by Pseudomonas aeruginosa exotoxina A. Infect Immun 1984; 45:227-233.
  55. Wieland C, Siegmund B, Senaldi G, Vasil M, Dinarello C, Fantuzzi G. Pulmonary inflammation induced by Pseudomonas aeruginosa lipopolysaccharide, phospholipase C, and exotoxin A: role of interferon regulatory factor 1. Infect Immun 2002; 70(3):1352-1358.
  56. Woods D, Schaffer M, Rabin H, Campbell G, Sokol P. Phenotypic Comparison of Pseudomonas aeruginosa strains isolated from a variety of clinical sites. Journal of clinical Microbiology 1986; 24(2):260-264.
Introducción
Materiales y Métodos
Resultados
Discusión
Referencias Bibliográficas

NOTA: Toda la información que se brinda en este artículo es de carácter investigativo y con fines académicos y de actualización para estudiantes y profesionales de la salud. En ningún caso es de carácter general ni sustituye el asesoramiento de un médico. Ante cualquier duda que pueda tener sobre su estado de salud, consulte con su médico o especialista.





Instituto de Medicina Tropical - Facultad de Medicina - Universidad Central de Venezuela.
Elaborado por el Centro de Análisis de Imágenes Biomédicas Computarizadas CAIBCO,
caibco@ucv.ve
Este portal ha sido desarrollado gracias al apoyo del Fonacit